regn stock market cap 2024

On December 31, Regeneron Pharmaceuticals (REGN) had a market capitalization of $81B, based on 113.8M shares at a price of $711.42.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
December 31 2024
$711.42
473,500
113,800,000
$80,959,118,040.00
December 30 2024
$701.69
537,200
113,800,000
$79,852,128,540.00
December 27 2024
$711.49
795,600
113,800,000
$80,967,072,660.00
December 26 2024
$715.76
619,200
113,800,000
$81,453,510,760.00
December 24 2024
$713.55
382,100
113,800,000
$81,202,331,400.00
December 23 2024
$714.21
866,500
113,800,000
$81,277,348,360.00
December 20 2024
$700.95
1,890,000
113,800,000
$79,768,018,960.00
December 19 2024
$707.34
1,086,700
113,800,000
$80,495,405,800.00
December 18 2024
$713.70
907,800
113,800,000
$81,219,378,640.00
December 17 2024
$739.06
978,700
113,800,000
$84,105,050,760.00
December 16 2024
$723.94
920,100
113,800,000
$82,384,337,860.00
December 13 2024
$730.36
696,900
113,800,000
$83,115,127,320.00
December 12 2024
$740.02
924,000
113,800,000
$84,214,162,200.00
December 11 2024
$772.01
776,800
113,800,000
$87,854,499,020.00
December 10 2024
$777.50
1,298,500
113,800,000
$88,479,591,040.00
December 09 2024
$786.99
1,027,300
113,800,000
$89,559,314,060.00
December 06 2024
$777.00
813,700
113,800,000
$88,422,770,700.00
December 05 2024
$766.91
779,000
113,800,000
$87,274,870,100.00
December 04 2024
$753.29
731,800
113,800,000
$85,724,629,600.00
December 03 2024
$748.61
649,800
113,800,000
$85,191,590,400.00
December 02 2024
$761.36
896,200
113,800,000
$86,642,950,080.00
November 29 2024
$749.26
489,800
113,800,000
$85,265,457,980.00
November 27 2024
$753.90
544,800
113,800,000
$85,793,956,560.00
November 26 2024
$752.06
779,800
113,800,000
$85,584,826,300.00
November 25 2024
$748.55
1,196,400
113,800,000
$85,184,773,780.00